Skip to content
GLP-1 Clinics Nearby
Safety and follow-upJuly 24, 2026 · 9 min read

GLP-1 side effects: what belongs in a real follow-up plan

Nausea, vomiting, diarrhea, constipation, and abdominal symptoms appear in current product information, but the complete risk profile is medication-specific.

Edited by

· Co-founder & CTO, Savo Group

B.S. in Computer Science, Oregon State University · B.A. in Psychology, University of Washington, Seattle

GLP-1 side-effects follow-up visit discussing gastrointestinal symptoms

Current status

Use the product-specific label

This overview helps prepare questions. It is not a complete adverse-effect list or a symptom-assessment tool.

Common category
Gastrointestinal
Best source
Current product label
Program must include
Clinical contact
At a glance

Match the question to the right source

A useful follow-up plan separates expected education from product-specific instructions and urgent clinical care.

Swipe horizontally to compare →

Match the question to the right source. A useful follow-up plan separates expected education from product-specific instructions and urgent clinical care.
QuestionBest sourceWhat to establish before treatment
What effects are common?Current product label and Medication GuideWhich symptoms to monitor and report
How do I use this product?Prescriber, pharmacist, and supplied instructionsProduct-specific administration and storage
When do I need urgent help?Prescribing team and emergency guidanceA clear same-day and urgent-care contact plan

Table source:FDA Wegovy prescribing information

01

Common does not mean identical across every product

Current prescribing information for weight-management products such as Wegovy and Zepbound lists gastrointestinal reactions among common adverse effects. The exact adverse reactions, frequencies, warnings, and contraindications differ by product and indication.

Use the Medication Guide and current FDA prescribing information for the product you receive. A provider summary should help you understand the label, not replace it. Our GLP-1 medication guide can help you identify the exact product before that conversation.

  • Nausea or vomiting
  • Diarrhea or constipation
  • Abdominal discomfort or pain
  • Changes in appetite or digestion
  • Product-specific reactions described in the current label

02

Know how to get help before the first dose

A program should tell you which symptoms require a routine message, a same-day clinical call, or urgent evaluation. That instruction needs to come from the prescribing team and product information—not from a directory.

Ask whether a licensed clinician is reachable after medication arrives, how quickly messages are reviewed, and what to do outside business hours. A customer-service inbox is not a substitute for clinical triage.

Seek urgent medical care for severe or rapidly worsening symptoms, signs of a serious allergic reaction, or any situation your clinician has told you is urgent. Do not wait for a directory or review site to respond.

03

Clear product and dose instructions reduce avoidable confusion

FDA has reported dosing errors involving compounded injectable semaglutide, including confusion about concentrations and measurement units. Multi-dose vials and syringes can create a different administration experience from a single-dose branded pen.

If a compounded product is prescribed for a specific medical need, ask the prescriber and pharmacy to show exactly how the labeled dose maps to the supplied concentration and measuring device. Never infer instructions from another patient’s vial or social-media post.

04

What to bring to the side-effect conversation

Give the prescriber a complete medication and supplement list, relevant medical and family history, prior reactions, pregnancy or breastfeeding context, and any upcoming procedures. Ask how the plan changes if symptoms persist or nutrition and hydration become difficult.

The goal is not to promise a side-effect-free experience. It is to know who is responsible, what to watch for, and how the plan will be adjusted safely.

Common questions

Answers to clarify the comparison

Are nausea and constipation common with GLP-1 medications?
They appear among common gastrointestinal adverse reactions in current labeling for some products. Frequency and management are product- and patient-specific.
When should I contact a clinician?
Follow the instructions from your prescribing team and the product Medication Guide. Ask for clear routine, same-day, and urgent contact guidance before treatment begins.
Do compounded GLP-1 products have the same side effects?
Compounded drugs are not FDA approved or reviewed for safety, effectiveness, or quality before marketing. FDA has also reported dosing errors and adverse events involving compounded products.

Primary sources

Read the official material behind this page

Health information is educational and does not diagnose, determine eligibility, or replace product labeling and care from a qualified professional.